References
- Skiba M., Wouessidjewe D., Coleman A., Fessi H., Devissaguet J.-P., Duchěne D., Puisieux F. Préparation et utilisation de nouveaux systèmes colloïdaux dispersibles à base de cyclodextrines, sous forme de nanospheres, PCT Application FR. 93/00594, 1993
- Fessi H., Puisieux F., Devissaguet J.-P. Precédé de préparation de systèmes colloïdaux dispersibles d'une substance sous forme de nanosphères, US Patent No. 5,118,528, 1988
- Skiba M., Puisieux F., Duchěne D., Wouessidjewe D. Direct imaging of modified β-cyclodextrin nanospheres by photon tunnelling and scanning force atomic microscopy. Int. J. Pharm. 1995; 120: 1–11
- Wouessidjewe D., Skiba M., Leroy-Lechat F., Lemos-Senna E., Puisieux F., Duchěne D. A new concept in drug delivery based on “skirt-shaped cyclodextrin aggregates”. Present state and future prospects. S. T. P. Pharma. Sci. 1996; 6: 21–28
- Leroy-Lechat F., Wouessidjewe D., Puisieux F., Duchěne D. Entrapment of doxorubicin in nanospheres of modified β- and γ-cyclodextrins. Proc. Int. Symp. Controlled Release Bioact. Mater. 1994; 21: 206–207
- Skiba M., Duchěne D., Puisieux F., Wouessidjewe D. Development of a new colloidal drug carrier from chemically-modified cyclodextrins: nanospheres and influence of physicochemical and technological factors on particle size. Int. J. Pharm. 1996; 129: 113–121
- Uekama K., Fujinaga T., Hirayama F., Otagiri M., Yamasaki M. Inclusion complexations of steroid hormones with cyclodextrins in water and solid phase. Int. J. Pharm. 1982; 10: 1–15
- Zhang P., Ling C. C., Coleman A., Parrot-Lopez H., Galons H. Formation of amphiphilic cyclodextrins via hydrophobic esterification at the secondary hydroxyl face. Tetrahedron Lett. 1991; 32: 2769–2770
- Keller G., Lavigne F., Loisel C., Ollivon M., Bourgaux C. Investigation of the complex behavior of fats. Combinated DSC and X-ray diffraction techniques. J. Therm. Anal. 1996; 47: 1545–1565
- Bjaastad S. G., Hall N., Thakkar A. L. Comparison of the solubilizing capacities of ionic and non-ionic surfactants for camphor. J. Pharm. Sci. 1965; 54(10)1529–1531
- Saski W., Shah S. G. Availability of drugs in the presence of surface-active agents I. Critical micelle concentration of some oxyethylene polymers. J. Pharm. Sci. 1965; 54(1)71–74
- Bahadur P., Riess G. Block copolymers—a special class of surfactants. Tenside Surfactants Deterg. 1991; 28(3)173–179
- Benoit J. P., Courteille F., Thies C. A physico-chemical study of the morphology of progesterone-loaded poly (D,L-lactide) microspheres. Int. J. Pharm. 1986; 29: 95–102
- Vandelli M. A., Forni F., Cameroni R. Analysis of release data in the evaluation of the physical state of progesterone in matrix systems. J. Microencapsulation 1993; 10(1)55–65
- Cameroni R., Gamberini G., Bernabe M. T., Facchini M. Preparazione e caratterizzazione delle forme polimorfe, Farmaco. Edizione Pratica 1973; 28: 621–635
- Ammoury N., Fessi H., Devissaguet J.-P., Puisieux F., Benita S. In vitro release kinetic pattern of indomethacin from poly (D,L-lactide) nanocapsules. J. Pharm. Sci. 1990; 79(8)1–5
- Skiba M., Wouessidjewe D., Puisieux F., Duchěne D., Gulik A. Characterization of amphiphilic p-cyclodextrin nanospheres. Int. J. Pharm. 1996; 142: 121–124
- Skiba M., Nemati F., Puisieux F., Duchene D., Wouessidjewe D. Spontaneous formation of drug-containing amphiphilic β-cyclodextrin nanocapsules. Int. J. Pharm. 1996; 145: 241–245
- Pitha J., Hoshino T. Effects of ethanol on formation of inclusion complexes of hydroxypropyl cyclodextrins with testosterone or with methyl orange. Int. J. Pharm. 1992; 80: 243–251